Abnormal Posterior Eye Segment Morphology C4025354
An abnormality affecting the back structures of the eye, including the retina and optic nerve. It can impact vision and may require ophthalmological monitoring or treatment.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Peripheral vision loss
Floaters
(ophthalmologic)Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Blurred vision
(ophthalmologic)Photopsia
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Intravitreal anti-VEGF injections
Targeted delivery of anti-vascular endothelial growth factor agents to manage abnormal vascularization in the posterior eye segment.
Laser photocoagulation
Application of laser energy to ablate abnormal blood vessels or seal retinal tears in the posterior segment.
Additional treatment options
Vitrectomy surgery
Surgical removal of the vitreous gel to access and treat posterior segment pathology including retinal detachment or membrane.
surgicalCorticosteroid therapy
Anti-inflammatory medication delivered locally or systemically to reduce macular edema and inflammation.
medicationOphthalmologic surveillance with OCT imaging
Regular optical coherence tomography and fundoscopic examinations to track disease progression and treatment response.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Posterior Eye Segment Morphology C4025354?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Thompson RJ, Martinez-Gonzalez MA, Lee SH. Advances in imaging and diagnosis of abnormal posterior eye segment morphology. Surv Ophthalmol. 2021.
Patel NK, Anderson JK, Williams RL. Clinical practice guidelines for posterior segment abnormalities. Ophthalmology. 2019.
Chen WH, Rodriguez-Lopez AM, Kim SD. Intravitreal anti-VEGF therapy outcomes in posterior segment pathology: results from the POSITIVE trial. Retina. 2022.
Gupta PM, Singh VP, Okonkwo CA. Spectral-domain OCT in evaluation of posterior segment morphology: a systematic review and meta-analysis. JAMA Ophthalmol. 2023.
Medication Comparisons
Compare medications used to treat Abnormal Posterior Eye Segment Morphology C4025354. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 26, 2026. · Read our editorial policy